Empagliflozin News

Empagliflozin currently has 12 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Empagliflozin with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: Type 2 diabetes mellitus Jardiance is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and...
Evidence level: L5
Predicted indications (20):
- classic stiff person syndrome (99.1%)
- focal stiff limb syndrome (99.1%)
- opsismodysplasia (99.0%)
- thiamine-responsive dysfunction syndrome (99.0%)
- diabetes mellitus (disease) (99.0%)
- drug-induced localized lipodystrophy (98.5%)
- centrifugal lipodystrophy (98.4%)
- pressure-induced localized lipoatrophy (98.3%)
- idiopathic localized lipodystrophy (98.2%)
- pancreatic agenesis (98.1%)
- autoimmune oophoritis (92.4%)
- type 1 diabetes mellitus (92.3%)
- homozygous familial hypercholesterolemia (88.1%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (72.7%)
- retinal dystrophy with or without extraocular anomalies (72.3%)
- diabetes mellitus, insulin-dependent, X-linked, susceptibility to (71.8%)
- Charcot-Marie-Tooth disease, demyelinating, type 1G (68.7%)
- myopia X-linked (68.0%)
- syndromic myopia (65.7%)
- atrial flutter (disease) (64.2%)